Bristol-Myers Squibb to Take Part in Leerink 6th Annual Global Health Care Conference

Category:

Wednesday, February 8, 2017 10:54 am EST

Dateline:

NEW YORK

Public Company Information:

NYSE:
BMY

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) will take part in the Leerink Annual Global Health Care Conference on Wednesday, February 15, 2017, in New York. Murdo Gordon, executive vice president and chief commercial officer, will answer questions about the company at 3:30 p.m. EST.

Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com. An archived edition of the session will be available later that day.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information, please visit www.bms.com or follow us on Twitter at http://twitter.com/bmsnews.

Contact:

Bristol-Myers Squibb
Media:
Ken Dominski, 609-252-5251
ken.dominski@bms.com
or
Investors:
Tim Power, 609-252-7509
timothy.power@bms.com
or
Bill Szablewski, 609-252-5894
william.szablewski@bms.com

Search Press Releases

Reset



Subscribe to E-Mail Alerts

Business Wire NewsHQ℠